Dongkook Pharmaceutical Supports COVID-19 Testing Costs for Children with Pediatric Cancer
[Asia Economy Reporter Lee Chun-hee] Dongkook Pharmaceutical announced on the 22nd that it will continue to support COVID-19 testing fees for children with pediatric cancer and their families through the Korea Leukemia Children's Foundation.
Since 2011, Dongkook Pharmaceutical has sponsored the Korea Leukemia Children's Foundation's "Our Family Happiness Outing" event for 10 years. However, as the event became difficult to hold due to the spread of COVID-19, since 2020, the company has been supporting the testing fees for COVID-19 negative certificates required when children with frequent hospitalizations for pediatric cancer and their families are admitted.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- The Unexpected Story of an American Man Who Won the Lottery 18 Times in 29 Years: "My Real Luck Is My Wife"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
A Dongkook Pharmaceutical official said, "We are supporting COVID-19 testing fees with the same heart as when we sponsored the 'spring outing' wishing for the speedy recovery of children with pediatric cancer," adding, "We hope this can help ease the financial burden on families even a little."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
